News: Novo Nordisk Q3 figures

Novo Nordisk a Danish pharmaceutical company specialized in diabetes care medications and devices just released their Q3 figures.

The highlights:

  • Net Sales +2%
  • Gross profit +1%
  • Net profit +2%
  • Earnings per share +5%
  • Outlook FY 2017 between 3%-6% net profit increase

Leave a Reply

Your email address will not be published. Required fields are marked *